Anne Cropp serves as the Chief Scientific Officer for Early Access Care, providing consultative, functional and operational support to biopharmaceutical companies for Expanded Access / Compassionate Use of investigational drugs. Prior to founding Early Access Care, Anne was Vice President in the Global Product Development Group of Pfizer Inc. Anne has extensive experience in pharmaceutical and biopharmaceutical drug development, marked by achievements in innovation and successful development of new drug products. Anne has held a number of global leadership positions in R&D. She is a globally recognized expert in early access/expanded access/compassionate use and led the development and execution of the industry's first physician-entry request portal for a global pharmaceutical company. She served as co-chair of the Pediatric Advisory Council for a Fortune-100 pharmaceutical company for more than 8 years. She has presented and chaired several international scientific symposia on early access and managed access.
Anne is a pharmacist and board-certified Clinical Pharmacologist. She earned her Doctor of Pharmacy degree from Duquesne University, her Bachelor of Science in Pharmacy from Massachusetts College of Pharmacy, and post-doctoral fellowships that included the National Institutes of Health. As a life long member of the scientific research community, Anne's passion has always been to bring solutions to advance patient care. Motivated by a desire to help patients, she founded Early Access Care.